Zimmer Biomet Holdings (ZBH) Net Cash Flow Growth (3y) (2012 - 2026)
Powered by 
Analysis
Zimmer Biomet Holdings (ZBH) Net Cash Flow Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn | -9.45% |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn | -16.59% |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn | -0.80% |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn | 60.16% |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | -85.83% |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn | 43.26% |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn | 1.60% |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn | -26.30% |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn | 269.22% |
| 10 | Zimmer Biomet Holdings | 18.00 Bn | 17.59 Bn | 1.54 Bn | -45.26% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -45.26% |
| Mar 31, 2026 | -51.65% |
| Dec 31, 2025 | -56.88% |
| Sep 30, 2025 | 62.68% |
| Jun 30, 2025 | -168.13% |
| Mar 31, 2025 | 96.57% |
| Dec 31, 2024 | 61.37% |
| Sep 30, 2024 | 47.61% |
| Jun 30, 2024 | -52.89% |
| Mar 31, 2024 | 40.31% |
| Dec 31, 2023 | 34.92% |
| Sep 30, 2023 | -28.00% |
| Jun 30, 2023 | 86.13% |
| Mar 31, 2023 | -26.55% |
| Dec 31, 2022 | -55.65% |
| Sep 30, 2022 | 14.00% |
| Jun 30, 2022 | 38.16% |
| Mar 31, 2022 | 37.78% |
| Dec 31, 2021 | -182.19% |
| Sep 30, 2021 | -63.92% |